Our Services
Our Services
Grow with us

We’re looking for entrepreneurs and teams with ideas that can make a difference. Through investments in technology-driven companies, we build long-term sustainable businesses that meet important societal needs.
Incubate
- Current companies
- Schedule a coffee
Accelerate
Globalize
- Current companies
- Contact us
Our Focus
Our Focus
Our mission & vision

Long-term investments in innovation and new technology within socially critical sectors to actively contribute to sustainable growth and social impact.
Investment philosophy

Money should be put to work and create new value.
Critical sectors

We strive to build long-term value by investing in companies that make a real difference.
Focus areas
Our Companies
About Us
About Us
About Sandberg Development
Other operations

Asset management and securities trading, management of the Group’s properties, as well as financing solutions for the Group’s portfolio companies service offerings.
Engagement
Engagement
Universities and colleges

A decisive collaboration to drive growth and social impact in our companies.
Research

A long-term commitment to research that creates benefits for people and society.
Social engagement

A society where everyone gets a chance to grow and develop.
Career
Career
Career at Sandberg Development
- Career opportunities
- Internships and thesis work
Graduate Program
- About the program
- EFL - Executive Education

Camurus

CEO: Fredrik Tiberg

Investment area: Quality of life

Investment year: 1991

Camurus develops and commercializes innovative, long-acting medicines for patients with severe and chronic diseases, such as addiction, pain, cancer, and endocrine disorders. The company's FluidCrystal® technology enables controlled drug release and sustained treatment efficacy over extended periods, aimed at delivering benefits to patients, caregivers, and society. Headquartered in Lund, Camurus operates across Europe, the US, and Australia. Its stock (CAMX) is listed on Nasdaq Stockholm.